GeneFerm Biotechnology Co., Ltd. (TPEX:1796)
Taiwan · Delayed Price · Currency is TWD 36.55
-0.65 (-1.75%)
Mar 26, 2026, 1:08 PM CST
GeneFerm Biotechnology Revenue
In the year 2025, GeneFerm Biotechnology had annual revenue of 677.10M TWD with 29.92% growth. GeneFerm Biotechnology had revenue of 177.21M in the quarter ending December 31, 2025, with 14.34% growth.
Revenue
677.10M
Revenue Growth
+29.92%
P/S Ratio
2.24
Revenue / Employee
4.70M
Employees
144
Market Cap
1.52B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 677.10M | 155.94M | 29.92% |
| Dec 31, 2024 | 521.16M | -272.61M | -34.34% |
| Dec 31, 2023 | 793.77M | 159.81M | 25.21% |
| Dec 31, 2022 | 633.96M | 111.63M | 21.37% |
| Dec 31, 2021 | 522.33M | 154.03M | 41.82% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| TSH Biopharm Corporation | 1.34B |
| Excelsior Biopharma | 898.26M |
| Anxo Pharmaceutical | 883.22M |
| Prince Pharmaceutical | 798.27M |
| Winston Medical Supply | 724.35M |
| DV Biomed | 712.61M |
| Tien Liang BioTech | 511.79M |
| Mediera | 229.85M |